To study the prevalence of ocular manifestations in patients with rheumatic disorders at Shree Krishna Hospital

Abstract Context: The rheumatic disorders (RDs) are a heterogeneous group of autoimmune and inflammatory diseases, including rheumatoid arthritis (RA), spondyloarthritis (SpA), Sjögren syndrome, systemic lupus erythematosus, sarcoidosis, and systemic sclerosis. Ocular manifestations include keratoconjunctivitis sicca, scleritis, episcleritis, and uveitis. As ocular involvement is common in rheumatoid diseases, with the help of this study, the prevalence of ocular manifestations can be evaluated and treated. Aims: To find out the prevalence of ocular manifestations in patients with rheumatoid disorders. Settings and Design: A cross-sectional study was conducted in the Outpatient Department of a tertiary care hospital. Materials and Methods: The study included 100 subjects, and they were asked for ocular and rheumatological symptoms associated with RD. Comprehensive ophthalmic examination, including visual acuity, color vision, Schirmer’s test, slit lamp examination, tear film break-up time, and fundus evaluation. Data was analyzed, and the risk factor association was calculated. Statistical Analysis Used: Descriptive statistics (mean [standard deviation], frequency [1%], etc.) will be used to present the profile of participants as well as the profile of ocular manifestations. Chi-square test/Fisher’s exact test will be employed to check the association of ocular manifestations with socio-demographic variables. Results: Out of 100 patients, 85% were females and 15% were males. The most affected age group is 41–60 years. RA (69.4%) was more common in females, whereas ankylosing SpA (40%) in males. Dry eye is the most common ocular finding, with 50% showing abnormal Schirmer’s test. Conclusions: RA is the most prevalent disease, especially in females aged 41–60. Dry eye is the most common ocular manifestation. The study found that RA and Sjogren syndrome are common in females, while ankylosing SpA in males. The use of hydroxychloroquine within recommended limits did not cause any ocular complications.